AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and Processes
Candidiasis, VulvovaginalCandidiasisCandidiasis, OralVaginal DiseasesCandida albicansVaginaVulvar DiseasesVulvovaginitisCandidiasis, InvasiveGynecological ExaminationVaginitisCandidaPruritus VulvaeCandidiasis, CutaneousAntifungal AgentsClotrimazoleVulvaCandidiasis, Chronic MucocutaneousVaginosis, BacterialBoric AcidsFluconazoleBalanitisCandida glabrataVaginal DischargeTrichomonas VaginitisDyspareuniaDrug Resistance, FungalVaginal NeoplasmsUterine CervicitisAdministration, IntravaginalRecurrenceAntibodies, FungalPharyngeal DiseasesEsophageal DiseasesPelvic Inflammatory DiseaseEchinocandinsAntigens, FungalCervix UteriOropharynxAmphotericin BSugar AlcoholsNucleic Acid Amplification TechniquesFungal VaccinesAdministration, OralFungemiaLipopeptidesCandidemiaAIDS-Related Opportunistic InfectionsMannans
Recurrent vulvovaginalRVVCAcute vulvovaginalPrevalence of vulvovaginal candidiasisInfectionsVaginitisChronic vulvovaginalFungal infectionSymptoms2021BacterialVaginal yeast infectionInfectionInvasive candidiasisSpeciesClotrimazolePandemicSporadicOropharyngealRegimensVIVJOAClinicalAntifungalPatientsAlbicansTherapeuticTreatmentCommonWomenBiofilmHttpsDiaperAdditionallyAffectsOccurDemandStudy
Recurrent vulvovaginal5
  • DURHAM, N.C.--(BUSINESS WIRE)-- Mycovia Pharmaceuticals, Inc. ("Mycovia"), an emerging biopharmaceutical company dedicated to recognizing and empowering those living with unmet medical needs by developing novel therapies, has announced that it will present topline results from two studies evaluating VIVJOA™ (oteseconazole) capsules in patients with recurrent vulvovaginal candidiasis (RVVC) at the 2022 Infectious Diseases Society for Obstetrics and Gynecology (IDSOG) Annual Meeting. (pharmiweb.com)
  • Background: Recurrent vulvovaginal candidiasis (VVC) is a difficult-to-manage condition that affects 5-8% of women of reproductive age. (monash.edu)
  • Is human dectin-1 Y238X gene polymorphism related to susceptibility to recurrent vulvovaginal candidiasis? (ac.ir)
  • Recurrent vulvovaginal candidiasis (RVVC) is common in otherwise healthy individuals. (ac.ir)
  • Although an optimal regimen has not yet been established for the treatment of recurrent vulvovaginal candidiasis, therapies include ketoconazole (400 mg/day), itraconazole (50-100 mg/day), fluconazole (100 mg/wk) for 6 weeks, and clotrimazole (500-mg vaginal suppositories once per wk). (medscape.com)
RVVC3
  • CD101 topical is being developed for the treatment of vulvovaginal candidiasis (VVC) and the prevention of recurrent VVC (RVVC), a prevalent mucosal infection. (biospace.com)
  • RVVC, also known as chronic yeast infection, is a distinct condition from vulvovaginal candidiasis (VVC) and defined by the Centers for Disease Control and Prevention as three or more symptomatic acute episodes of yeast infection in 12 months. (pharmiweb.com)
  • Materials and Methods: In the current study, blood samples were obtained from 25 patients who had frequent vulvovaginal candidiasis relapses and were diagnosed as RVVC. (ac.ir)
Acute vulvovaginal3
  • SAN DIEGO--( BUSINESS WIRE )--Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other infections, today announced that the first patient has been dosed in RADIANT, a Phase 2 clinical trial comparing the safety and tolerability of the novel echinocandin, CD101, to standard-of-care fluconazole for the treatment of acute vulvovaginal candidiasis (VVC). (biospace.com)
  • In acute vulvovaginal candidiasis, vulvar pruritus and burning are the main symptoms. (medscape.com)
  • Number of acute vulvovaginal candida infections [Regular structured clinical interviews with a member of the research team monthly throughout the study Monitored monthly post-treatment commencement for 6 months. (who.int)
Prevalence of vulvovaginal candidiasis4
  • We investigated the prevalence of vulvovaginal candidiasis due to C. africana in an STD clinic in India and analysed the genetic relatedness of these C. africana isolates with those outside India. (mcmaster.ca)
  • The study was carried out to determine the prevalence of vulvovaginal candidiasis among women suffering vaginitis. (ejua.net)
  • Direct microscopic examination (10% KOH), culture on SDA, germ tube test and gram staining were used to determine the prevalence of vulvovaginal candidiasis and to differentiate between C.albicans and non-albicans species. (ejua.net)
  • No statistically significant association between the prevalence of vulvovaginal candidiasis and educational level and marital status. (ejua.net)
Infections8
  • The Centers for Disease Control and Prevention (CDC) guidelines recommend using only topical antifungal products to treat pregnant women with vulvovaginal yeast infections. (biospace.com)
  • The rise in vulvovaginal candidiasis infections in women around the world, rising regulatory approvals for vulvovaginal candidiasis treatments, and an increase in clinical research studies into vulvovaginal candidiasis treatments are key factors propelling this market's revenue growth. (mrbusinestech.com)
  • Yeast infections (candidiasis) happen when too much candida grows in the vagina. (medlineplus.gov)
  • Also called vaginal candidiasis, vaginal yeast infections affect up to 75 percent of people with a vagina at some point in their lifetime. (healthline.com)
  • Candidiasis is the second most common cause of vaginal infections in the US. (jogcr.com)
  • a) candidiasis causes a wide range of infections, b) invasive and systemic infections has high lethal rate, c) the number of patients prone to various fungal diseases (e.g. candidiasis) is increasing, d) new molecular biological techniques are used to identify Candida species in VVC isolates (1). (jogcr.com)
  • Yeast infections (also known as candidiasis) are common infections caused by Candida albicans yeast, which is a type of fungus . (kidshealth.org)
  • Most candidal infections are of the skin and mucous membranes, but invasive candidiasis is common among patients who are immunosuppressed and can be life threatening. (msdmanuals.com)
Vaginitis1
Chronic vulvovaginal4
  • Clinical samples were collected from 70 women aged 40-50 years old, married with children and referred for chronic vulvovaginal complaints. (ajbls.com)
  • Majdabadi N, Falahati M, Heidarie-Kohan F, Farahyar S, Rahimi-Moghaddam P, Ashrafi-Khozani M. Study on synergistic effect of 2-phenylethanol and clotrimazole on candida species isolated from patients with chronic vulvovaginal candidiasis. (ac.ir)
  • Chronic vulvovaginal candidiasis is a vulvovaginal inflammation which is caused by Candida spp. (ac.ir)
  • In order to improve the treatment, the effect of 2-phenyl ethanol was investigated in combination with clotrimazole on Candida species isolated from chronic vulvovaginal candidiasis. (ac.ir)
Fungal infection3
Symptoms4
20211
  • The market for Vulvovaginal Candidiasis (VVC) was valued at USD 971.51 million in 2021 and is anticipated to grow at a 4.2% CAGR in terms of revenue during the projected period. (mrbusinestech.com)
Bacterial3
  • The recent demonstration of a vaginal biofilm in bacterial vaginosis and its postulated importance in the pathogenesis of recurrent bacterial vaginosis, including relative resistance to therapy, has led to the hypothesis that biofilms are crucial for the development of vulvovaginal candidiasis. (interlabservice.ru)
  • In a cross-sectional study, vaginal tissue biopsies were obtained from 35 women with clinically, microscopically, and culture-proven vulvovaginal candidiasis and compared with specimens obtained from 25 healthy women and 30 women with active bacterial vaginosis. (interlabservice.ru)
  • The majority of uncomplicated vulvovaginal complaints (e.g. bacterial vaginosis, vulvovaginal candidiasis, trichomoniasis) can be detected with uncomplicated basic infectiological tests and can usually be treated effectively without requiring further diagnostic procedures. (thieme-connect.de)
Vaginal yeast infection2
  • Scynexis Inc.,. announced that the FDA has approved Brexafemme(ibrexafungerp tablets), for oral use in patients with vulvovaginal candidiasis (VVC), also known as vaginal yeast infection. (medicalupdateonline.com)
  • Background & Objective: Vulvovaginal candidiasis (VVC) is a common vaginal yeast infection in women. (jogcr.com)
Infection6
Invasive candidiasis2
  • Individuals at risk for invasive candidiasis include low birth weight babies, people recovering from surgery, people admitted to intensive care units, and those with an otherwise compromised immune system. (wikipedia.org)
  • The incidence of hospital-acquired, invasive candidiasis increased 10-fold over the decade of the 1980s. (cdc.gov)
Species1
  • Background and Purpose: Vulvovaginal candidiasis is a frequent disease affecting approximately more than %75 of all childbearing women at least once in their lifetime by overgrowth of opportunistic Candida species. (ac.ir)
Clotrimazole1
Pandemic2
Sporadic1
  • Uncomplicated sporadic vulvovaginal candidiasis usually is caused by strains of C albicans (see the image below). (medscape.com)
Oropharyngeal1
Regimens1
  • A number of antimycotic regimens are available for the treatment of vulvovaginal candidiasis, including with oral and topical agents. (medscape.com)
VIVJOA1
  • U.S. participants in the VIOLET studies treated with a 12-week course of VIVJOA who did not experience a vulvovaginal candidiasis (VVC) episode during the 48-week study were offered the opportunity to participate in an extension study, during which they were monitored for an additional 48 weeks (96 weeks total). (pharmiweb.com)
Clinical2
  • The clinical picture of chronic, persistent vulvovaginal candidiasis differs in that it includes marked edema and lichenification of the vulva with poorly defined margins. (medscape.com)
  • Candidiasis encompasses a wide variety of clinical syndromes caused by Candida . (jogcr.com)
Antifungal2
  • The study concluded that we can formulate a novel antifungal agent of natural origin from S. cerevisiae which could be used as a cheaper alternative for the therapeutic management of vulvovaginal candidiasis. (ajbls.com)
  • The aim of this study was to evaluate the antifungal activity of Syngonanthus nitens (S. nitens) extract that was not loaded (E) or loaded (SE) into a liquid crystal precursor system (S) for the treatment of vulvovaginal candidiasis (VVC) with Candida albicans. (who.int)
Patients1
  • Patients with chronic candidiasis are usually older and obese and often have long-standing diabetes mellitus. (medscape.com)
Albicans1
Therapeutic1
  • associated to vulvovaginal candidiasis and compared their efficacy to other therapeutic alternatives. (ajbls.com)
Treatment1
Common1
Women5
  • About 5% of all women will experience chronic or repeated episodes of vulvovaginal candidasis. (knowthecause.com)
  • Vulvovaginal candidiasis in posthormonal women: The role of hormone replacement therapy. (knowthecause.com)
  • Use of estrogen replacement therapy in postmenopausal and perimenopausal women may increase risk of vulvovaginal candidiasis. (knowthecause.com)
  • Although not statistically significant, vulvovaginal candidiasis tended to be more prevalent among women with 25-34 years. (ejua.net)
  • The Pearson correlation coefficient showed that 16.9% of the women had oral herpes and oral candidiasis. (bvsalud.org)
Biofilm1
  • The present study aimed at clarifying the histopathology of vulvovaginal candidiasis including the presence or absence of vaginal biofilm. (interlabservice.ru)
Https2
  • 2014. https://emergency.unboundmedicine.com/emergency/view/Diagnosaurus/114800/all/Vulvovaginal_candidiasis. (unboundmedicine.com)
  • 2015. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545027/3.2/Candidiasis_vulvovaginal. (hopkinsguides.com)
Diaper1
  • Candidiasis occurs most commonly in intertriginous areas such as the axillae, groin, and gluteal folds (eg, diaper rash), in digital web spaces, on the glans penis, and beneath the breasts. (msdmanuals.com)
Additionally1
  • The Vulvovaginal Candidiasis market report additionally provides details such as import/export consumption, supply and demand figures, cost, price, revenue, and gross margins. (healthcarenewsreports.com)
Affects1
Occur1
Demand1
Study2
  • This study will be presented by Dr. Paul Nyirjesy, professor of Obstetrics and Gynecology at Thomas Jefferson University and co-director of the Jefferson Vulvovaginal Health Center, during Poster Session 1 on Thursday, Aug. 4, from 10:05 to 11:05 a.m. (pharmiweb.com)
  • The Vulvovaginal Candidiasis market analysis summary by Market Research Store is a comprehensive study of the recent trends leading to market development in various regions. (healthcarenewsreports.com)